| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 66.5 | - | - | - | - | - | - | 0.5 | - | - | 67.0 |
| 1 | 10.5 | - | - | - | - | - | - | - | - | - | 10.5 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 792 |
| 1 | 204 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 264 |
| 1 | 61 |
| Number of post synapses: | 134 |
| Number of pre synapses: | 21 |
| Number of output connections: | 56 |
| Coverage factor: | 1.2 |
| Columnar completeness: | 0.02 |
| Area completeness: | 0.03 |
| Cell size (columns): | 13 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe1 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe4 (R) | ACh | 410 | 205.0 | 18.1% | 18.1% |
| 1 | aMe6b (R) | ACh | 191 | 95.5 | 8.5% | 26.6% |
| 2 | aMe5 (R) | ACh | 185 | 92.5 | 8.2% | 34.8% |
| 3 | aMe6c (R) | Glu | 162 | 81.0 | 7.2% | 41.9% |
| 4 | aMe1 (R) | GABA | 161 | 80.5 | 7.1% | 49.1% |
| 5 | aMe2 (R) | Glu | 159 | 79.5 | 7.0% | 56.1% |
| 6 | MeVPMe12 (L) | ACh | 154 | 77.0 | 6.8% | 62.9% |
| 7 | MeVP1 (R) | ACh | 150 | 75.0 | 6.6% | 69.6% |
| 8 | aMe30 (R) | Glu | 84 | 42.0 | 3.7% | 73.3% |
| 9 | aMe10 (L) | ACh | 79 | 39.5 | 3.5% | 76.8% |
| 10 | aMe3 (R) | Glu | 71 | 35.5 | 3.1% | 79.9% |
| 11 | aMe6a (R) | ACh | 53 | 26.5 | 2.3% | 82.3% |
| 12 | aMe22 (R) | Glu | 40 | 20.0 | 1.8% | 84.0% |
| 13 | MeVCMe1 (L) | ACh | 40 | 20.0 | 1.8% | 85.8% |
| 14 | MeVCMe1 (R) | ACh | 34 | 17.0 | 1.5% | 87.3% |
| 15 | MeVC20 (R) | Glu | 33 | 16.5 | 1.5% | 88.8% |
| 16 | aMe12 (R) | ACh | 28 | 14.0 | 1.2% | 90.0% |
| 17 | MeVP11 (R) | ACh | 28 | 14.0 | 1.2% | 91.2% |
| 18 | SLP250 (R) | unclear | 24 | 12.0 | 1.1% | 92.3% |
| 19 | OA-AL2i3 (R) | OA | 20 | 10.0 | 0.9% | 93.2% |
| 20 | MeVP49 (R) | unclear | 16 | 8.0 | 0.7% | 93.9% |
| 21 | aMe10 (R) | ACh | 14 | 7.0 | 0.6% | 94.5% |
| 22 | HBeyelet (R) | His | 12 | 6.0 | 0.5% | 95.0% |
| 23 | MeVPaMe2 (L) | Glu | 10 | 5.0 | 0.4% | 95.5% |
| 24 | PLP211 (R) | unclear | 8 | 4.0 | 0.4% | 95.8% |
| 25 | aMe12 (L) | ACh | 7 | 3.5 | 0.3% | 96.2% |
| 26 | L3 (R) | ACh | 7 | 3.5 | 0.3% | 96.5% |
| 27 | aMe24 (R) | unclear | 6 | 3.0 | 0.3% | 96.7% |
| 28 | SLP249 (R) | unclear | 6 | 3.0 | 0.3% | 97.0% |
| 29 | MeVPMe3 (L) | Glu | 5 | 2.5 | 0.2% | 97.2% |
| 30 | aMe17c (R) | Glu | 4 | 2.0 | 0.2% | 97.4% |
| 31 | MeVPMe4 (L) | Glu | 4 | 2.0 | 0.2% | 97.6% |
| 32 | OCG02c (L) | unclear | 4 | 2.0 | 0.2% | 97.7% |
| 33 | 5thsLNv_LNd6 (R) | ACh | 3 | 1.5 | 0.1% | 97.9% |
| 34 | aMe23 (R) | unclear | 3 | 1.5 | 0.1% | 98.0% |
| 35 | Cm35 (R) | GABA | 3 | 1.5 | 0.1% | 98.1% |
| 36 | LoVCLo3 (R) | OA | 3 | 1.5 | 0.1% | 98.3% |
| 37 | MeLo1 (R) | ACh | 3 | 1.5 | 0.1% | 98.4% |
| 38 | MeVC3 (L) | ACh | 3 | 1.5 | 0.1% | 98.5% |
| 39 | Tm5c (R) | Glu | 3 | 1.5 | 0.1% | 98.7% |
| 40 | aMe_TBD1 (R) | unclear | 2 | 1.0 | 0.1% | 98.8% |
| 41 | Cm20 (R) | GABA | 2 | 1.0 | 0.1% | 98.8% |
| 42 | l-LNv (R) | unclear | 2 | 1.0 | 0.1% | 98.9% |
| 43 | l-LNv (L) | unclear | 2 | 1.0 | 0.1% | 99.0% |
| 44 | LoVC21 (L) | GABA | 2 | 1.0 | 0.1% | 99.1% |
| 45 | Mi15 (R) | ACh | 2 | 1.0 | 0.1% | 99.2% |
| 46 | PLP080 (R) | unclear | 2 | 1.0 | 0.1% | 99.3% |
| instance | NT | total connections | connections /#aMe1 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe17c (R) | Glu | 215 | 107.5 | 10.4% | 10.4% |
| 1 | CL125 (R) | unclear | 209 | 104.5 | 10.1% | 20.4% |
| 2 | aMe1 (R) | GABA | 161 | 80.5 | 7.8% | 28.2% |
| 3 | Lat2 (R) | unclear | 134 | 67.0 | 6.5% | 34.6% |
| 4 | SLP250 (R) | unclear | 133 | 66.5 | 6.4% | 41.0% |
| 5 | 5thsLNv_LNd6 (R) | ACh | 115 | 57.5 | 5.5% | 46.6% |
| 6 | Lat1 (R) | unclear | 110 | 55.0 | 5.3% | 51.9% |
| 7 | aMe6b (R) | ACh | 105 | 52.5 | 5.1% | 56.9% |
| 8 | aMe_TBD1 (R) | unclear | 80 | 40.0 | 3.9% | 60.8% |
| 9 | SLP249 (R) | unclear | 77 | 38.5 | 3.7% | 64.5% |
| 10 | aMe20 (R) | unclear | 59 | 29.5 | 2.8% | 67.3% |
| 11 | PLP211 (R) | unclear | 59 | 29.5 | 2.8% | 70.2% |
| 12 | MeVP63 (R) | GABA | 50 | 25.0 | 2.4% | 72.6% |
| 13 | aMe17e (R) | Glu | 41 | 20.5 | 2.0% | 74.6% |
| 14 | aMe3 (R) | Glu | 40 | 20.0 | 1.9% | 76.5% |
| 15 | MeVP11 (R) | ACh | 37 | 18.5 | 1.8% | 78.3% |
| 16 | MeVC22 (R) | Glu | 35 | 17.5 | 1.7% | 80.0% |
| 17 | aMe15 (R) | unclear | 33 | 16.5 | 1.6% | 81.6% |
| 18 | l-LNv (R) | unclear | 30 | 15.0 | 1.4% | 83.0% |
| 19 | LoVP96 (R) | Glu | 22 | 11.0 | 1.1% | 84.1% |
| 20 | SMP200 (R) | unclear | 22 | 11.0 | 1.1% | 85.1% |
| 21 | SMP217 (R) | unclear | 18 | 9.0 | 0.9% | 86.0% |
| 22 | aMe6c (R) | Glu | 16 | 8.0 | 0.8% | 86.8% |
| 23 | aMe8 (R) | ACh | 16 | 8.0 | 0.8% | 87.5% |
| 24 | aMe30 (R) | Glu | 15 | 7.5 | 0.7% | 88.2% |
| 25 | LT58 (R) | Glu | 15 | 7.5 | 0.7% | 89.0% |
| 26 | DNpe021 (R) | unclear | 14 | 7.0 | 0.7% | 89.6% |
| 27 | aMe10 (R) | ACh | 13 | 6.5 | 0.6% | 90.3% |
| 28 | aMe26 (R) | ACh | 13 | 6.5 | 0.6% | 90.9% |
| 29 | aMe6a (R) | ACh | 10 | 5.0 | 0.5% | 91.4% |
| 30 | MeVPaMe2 (L) | Glu | 10 | 5.0 | 0.5% | 91.9% |
| 31 | MeVPaMe1 (L) | ACh | 8 | 4.0 | 0.4% | 92.2% |
| 32 | Dm20 (R) | Glu | 7 | 3.5 | 0.3% | 92.6% |
| 33 | MeLo2 (R) | ACh | 7 | 3.5 | 0.3% | 92.9% |
| 34 | Tm5c (R) | Glu | 7 | 3.5 | 0.3% | 93.3% |
| 35 | aMe10 (L) | ACh | 6 | 3.0 | 0.3% | 93.5% |
| 36 | aMe2 (R) | Glu | 6 | 3.0 | 0.3% | 93.8% |
| 37 | aMe5 (R) | ACh | 6 | 3.0 | 0.3% | 94.1% |
| 38 | Lat5 (R) | unclear | 6 | 3.0 | 0.3% | 94.4% |
| 39 | Tm16 (R) | ACh | 6 | 3.0 | 0.3% | 94.7% |
| 40 | aMe12 (R) | ACh | 5 | 2.5 | 0.2% | 94.9% |
| 41 | aMe22 (R) | Glu | 5 | 2.5 | 0.2% | 95.2% |
| 42 | aMe4 (R) | ACh | 5 | 2.5 | 0.2% | 95.4% |
| 43 | LoVP53 (R) | ACh | 5 | 2.5 | 0.2% | 95.7% |
| 44 | MeLo6 (R) | ACh | 5 | 2.5 | 0.2% | 95.9% |
| 45 | MeVPaMe1 (R) | ACh | 5 | 2.5 | 0.2% | 96.1% |
| 46 | Lat3 (R) | unclear | 4 | 2.0 | 0.2% | 96.3% |
| 47 | Mi18 (R) | GABA | 4 | 2.0 | 0.2% | 96.5% |
| 48 | OCG02c (L) | unclear | 4 | 2.0 | 0.2% | 96.7% |
| 49 | TmY5a (R) | Glu | 4 | 2.0 | 0.2% | 96.9% |
| 50 | aMe13 (R) | unclear | 3 | 1.5 | 0.1% | 97.1% |
| 51 | aMe24 (R) | unclear | 3 | 1.5 | 0.1% | 97.2% |
| 52 | Cm20 (R) | GABA | 3 | 1.5 | 0.1% | 97.4% |
| 53 | Li20 (R) | Glu | 3 | 1.5 | 0.1% | 97.5% |
| 54 | MeVC20 (R) | Glu | 3 | 1.5 | 0.1% | 97.6% |
| 55 | MeVPMe12 (L) | ACh | 3 | 1.5 | 0.1% | 97.8% |
| 56 | aMe17a (R) | Glu | 2 | 1.0 | 0.1% | 97.9% |
| 57 | aMe23 (R) | unclear | 2 | 1.0 | 0.1% | 98.0% |
| 58 | Lawf1 (R) | ACh | 2 | 1.0 | 0.1% | 98.1% |
| 59 | LoVP50 (R) | ACh | 2 | 1.0 | 0.1% | 98.2% |
| 60 | MeLo1 (R) | ACh | 2 | 1.0 | 0.1% | 98.3% |
| 61 | MeVP1 (R) | ACh | 2 | 1.0 | 0.1% | 98.4% |
| 62 | MeVP30 (R) | ACh | 2 | 1.0 | 0.1% | 98.5% |
| 63 | Mi19 (R) | 5HT | 2 | 1.0 | 0.1% | 98.6% |
| 64 | Pm12 (R) | Glu | 2 | 1.0 | 0.1% | 98.7% |
| 65 | Pm8 (R) | GABA | 2 | 1.0 | 0.1% | 98.7% |
| 66 | PS272 (R) | unclear | 2 | 1.0 | 0.1% | 98.8% |